Showing results (411-420 of 569) with videos related to

Sort By:
Pageof 57
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluidYvette van Hensbergen, Henk J Broxterman, Roeland Hanemaaijer, et al.
British Journal of Cancer|May 11, 2006
CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cellsD Fontijn, M C A Duyndam, M P A van Berkel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) studyE E Holdener, M Clavel, C Sessa, et al.
Sexually Transmitted Infections|October 13, 2017
High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccineDesiree J Hooi, Birgit I Lissenberg-Witte, Maurits N C de Koning, et al.
British Journal of Cancer|January 1, 1997
Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stainH J Broxterman, G J Schuurhuis, J Lankelma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancerRutger Middelburg, Richard R de Haas, Henk Dekker, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in miceG Codacci-Pisanelli, C L van der Wilt, H M Pinedo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancerS M De Lange, C J van Groeningen, J R Kroep, et al.
Biochemical Pharmacology|February 5, 1999
Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinaseA M Bergman, H M Pinedo, A P Jongsma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2002
Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patientsB C Kuenen, M Levi, J C M Meijers, et al.
Pageof 57